Fresenius SE & Co. KGaA (FSNUY)
Fresenius SE & Co. KGaA operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Bad Homburg vor der Höhe, HE, DE. The stock last traded at $13.28, up 0.91% on the session, giving a market capitalisation of $119.68B. On trailing twelve-month figures it carries a trailing P/E of 16.78, a net margin of 6.5%. Its beta of 0.83 implies it has historically moved less than the broad market.
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.
Fresenius SE & Co. KGaA is most often compared with the following Healthcare names: